Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Online ahead of print]

Effect of Dextrose Prolotherapy on Pain Intensity, Disability and Plantar Fascia Thickness in Unilateral Plantar Fasciitis: A Randomized, Controlled, Double-Blind Study

Affiliations

Effect of Dextrose Prolotherapy on Pain Intensity, Disability and Plantar Fascia Thickness in Unilateral Plantar Fasciitis: A Randomized, Controlled, Double-Blind Study

Basak Mansiz-Kaplan et al. Am J Phys Med Rehabil.

Abstract

Objective: To evaluate the efficacy of dextrose prolotherapy in the treatment of chronic resistant plantar fasciitis (PF) through comparison with a control group.

Design: In this double-blind, randomized, controlled study, the patients were divided into two groups. The prolotherapy group (n=30) was administered 5 cc 30% dextrose, 4 cc saline, 1cc 2% lidocaine mixture (15% dextrose solution) and the control group was given 9 cc saline and 1 cc 2% lidocaine mixture twice at a three-week interval. During the fifteen-week follow-up period, pain intensity was measured using the visual analog scale during activity (VAS-A) and at rest (VAS-R). The foot function index (FFI) was used to measure pain and disability. The plantar fascia thickness was measured by ultrasonography. The measurements were undertaken before treatment and at post-treatment weeks 7 and 15.

Results: Improvements in VAS-A, VAS-R, FFI (all subgroups), and plantar fascia thickness measured at the 7th and 15th weeks were significantly higher in the prolotherapy group compared to the control group (p>0.001).

Conclusion: Dextrose prolotherapy has efficacy up to 15 weeks and can be used as an alternative method in the treatment of chronic resistant PF.

Similar articles

See all similar articles

LinkOut - more resources

Feedback